🎥 VIDEO: Most Monoclonal Antibody Treatments Fail Against OMICRON VARIANT
jamescintolo.substack.com
Most key monoclonal antibody treatments including Eli Lilly, AstraZeneca, and Regeneron are not working against OMICRON. On 11/26/21 the World Health Organization classified a new SARS-CoV-2 variant named B.1.1.529, more popularly known as OMICRON, and certified it as a novel VOC (variant of concern). Within days, questions regarding current vaccine and therapeutic efficacy against the newly discovered progeny surfaced. Simultaneously, genetic sequencing out of Botswana revealed a multitude of genomic changes in the new variant which further sparked international debate over possible immune escape, waning protection from primary series of COVID-19 vaccinations, and the possibility of reduced monoclonal antibody efficacy. Soon after, studies began to surface showing decreased effectiveness of current monoclonal antibody treatments against omicron.
🎥 VIDEO: Most Monoclonal Antibody Treatments Fail Against OMICRON VARIANT
🎥 VIDEO: Most Monoclonal Antibody Treatments…
🎥 VIDEO: Most Monoclonal Antibody Treatments Fail Against OMICRON VARIANT
Most key monoclonal antibody treatments including Eli Lilly, AstraZeneca, and Regeneron are not working against OMICRON. On 11/26/21 the World Health Organization classified a new SARS-CoV-2 variant named B.1.1.529, more popularly known as OMICRON, and certified it as a novel VOC (variant of concern). Within days, questions regarding current vaccine and therapeutic efficacy against the newly discovered progeny surfaced. Simultaneously, genetic sequencing out of Botswana revealed a multitude of genomic changes in the new variant which further sparked international debate over possible immune escape, waning protection from primary series of COVID-19 vaccinations, and the possibility of reduced monoclonal antibody efficacy. Soon after, studies began to surface showing decreased effectiveness of current monoclonal antibody treatments against omicron.